SCHEMBL6541877

SCHEMBL6541877

CC1(N2Cc3cccc(NCc4ccccc4)c3C2)CC(O)C(=O)NC1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 2/20 0.42
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
HSD17B10 Q99714 1/20 0.34
HDAC6 Q9UBN7 2/20 0.33
GRM2 Q14416 1/20 0.33
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
CCNA1 P78396 1/20 0.32
MEN1 O00255 1/20 0.32
APEX1 P27695 1/20 0.32
KMT2A Q03164 1/20 0.32
FNTA P49354 1/20 0.32
FNTB P49356 1/20 0.32
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3743954 0.82 CRBN (0.42) CARM1DDB1CRBNHSD17B10GRM2
SCHEMBL3756718 0.77 DDB1 (0.52) DDB1CRBNHSD17B10MEN1KMT2A
SCHEMBL3738115 0.72 CRBN (0.43) CARM1DDB1CRBNRXRARXRB
SCHEMBL3754054 0.68 DDB1 (0.53) DDB1CRBNHSD17B10MEN1KMT2A
SCHEMBL5156983 0.66 CRBN (0.48) DDB1CRBNBRD4
SCHEMBL31335890 0.63 ACHE (0.48) CARM1DDB1CRBNRXRARXRB
SCHEMBL5123728 0.62 RXRA (0.51) CARM1DDB1CRBNRXRARXRB
SCHEMBL31335894 0.62 HSP90AA1 (0.51) CARM1
SCHEMBL31335873 0.61 HSP90AA1 (0.60)
SCHEMBL1080603 0.61 RXRA (0.44) CARM1RXRARXRBRXRGHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1341537-A4 PHARMACEUTICALLY ACTIVE ISOINDOLINE DERIVATIVES CELGENE CORP (US) 2004-01-28 EP disclosed
EP-1341537-A2 PHARMACEUTICALLY ACTIVE ISOINDOLINE DERIVATIVES CELGENE CORPORATION (US) 2003-09-10 EP disclosed
WO-2002094180-A2 PHARMACEUTICALLY ACTIVE ISOINDOLINE DERIVATIVES CELGENE CORPORATION (US) 2002-11-28 WO disclosed